Sort
34,240 grants matching “atherosclerosis”
Mechanisms and Consequences of Stress-Induced Macrophage Death in Atherosclerosis
$394,000Ira A Tabas · Columbia University Health Sciences · R01 · FY2015 · HL
Role of apolipoprotein E4 in the progression and regression of atherosclerosis
$394,000Robert Raffai · Northern California Institute/Res/Edu · R01 · FY2010 · HL
Role of apolipoprotein E4 in the progression and regression of atherosclerosis
$394,000Robert Raffai · Northern California Institute/Res/Edu · R01 · FY2011 · HL
p90RSK-ERK5 module, efferocytosis, and vulnerable plaque formation
$394,000Jun-Ichi Abe · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · HL
Role of apolipoprotein E4 in the progression and regression of atherosclerosis
$394,000Robert Raffai · Northern California Institute/Res/Edu · R01 · FY2009 · HL
Vascular Endothelial Activation in Sleep Apnea
$394,000Sanja Jelic · Columbia University Health Sciences · R01 · FY2015 · HL
Endothelial dysfunction in aged Trx-deficient mice.
$393,995Kumuda C Das · Texas Tech University Health Scis Center · R01 · FY2013 · HL
Longitudinal SIT Trial Plasma Proteomic Biomarker Discovery and Validation in SCI
$393,994James F Casella · Johns Hopkins University · R01 · FY2010 · HL
Micro-RNA reprogrammed human CD34 stem cells for cardiovascular disease therapy
$393,977Keith A Webster · University Of Miami School Of Medicine · R01 · FY2012 · HL
Micro-RNA reprogrammed human CD34 stem cells for cardiovascular disease therapy
$393,975Keith A Webster · University Of Miami School Of Medicine · R01 · FY2011 · HL
Renin-Angiotensin and Fibrinolysis Interaction in Humans
$393,947Nancy Joan Brown · Vanderbilt University · R01 · FY2007 · HL
Mechanisms of Glycosaminoglycan-Catalyzed Protease Inactivation by Serpins
$393,752Ingrid M Verhamme · Vanderbilt University Medical Center · R01 · FY2017 · HL
Exploring the fundamental cellular mechanisms driving cellular senescence in macrophages
$393,750Anthony Joseph Covarrubias · University Of California Los Angeles · R35 · FY2025 · GM
Central actions of angiotensin II in the control of fluid balance
$393,750Daniel K Yee · University Of Pennsylvania · R01 · FY2009 · HL
HDL metabolism: Influence of extracellular lipases
$393,750Daniel James Rader · University Of Pennsylvania · R37 · FY2010 · HL
Selective regulation of macrophage activation
$393,750Xiaoyu Hu · Hospital For Special Surgery · R01 · FY2010 · AR
Central actions of angiotensin II in the control of fluid balance
$393,750Daniel K Yee · University Of Pennsylvania · R01 · FY2010 · HL
Clearance of macrophage p62-enriched protein aggregates as a therapy for Atherosclerosis
$393,750Babak Razani · Washington University · R01 · FY2020 · HL
Lipidation and Vascular Disease
$393,750Clay F. Semenkovich · Washington University · R01 · FY2021 · HL
Central actions of angiotensin II in the control of fluid balance
$393,750Daniel K Yee · University Of Pennsylvania · R01 · FY2011 · HL
HDL metabolism: Influence of extracellular lipases
$393,750Daniel James Rader · University Of Pennsylvania · R37 · FY2009 · HL
HDL metabolism: Influence of extracellular lipases
$393,750Daniel James Rader · University Of Pennsylvania · R37 · FY2011 · HL
Lipidation and Vascular Disease
$393,750Clay F. Semenkovich · Washington University · R01 · FY2023 · HL
Genetics of Vascular Remodeling
$393,750University Of Rochester · R01 · FY2005 · HL
Lipidation and Vascular Disease
$393,750Clay F. Semenkovich · Washington University · R01 · FY2022 · HL